KB Components AB (publ) (Ticker: 5G7.F) manufactures and supplies precision metal components and assemblies primarily for the medical device, life science, and industrial sectors. The company offers core products and services including CNC machining of high-precision parts in materials such as titanium, stainless steel, aluminum, and plastics; turned and milled components with tolerances down to microns; complex assemblies and sub-assemblies; surface treatments and coatings; and prototyping and low-to-medium volume production capabilities. KB Components serves original equipment manufacturers (OEMs) with customized solutions focused on quality, reliability, and regulatory compliance, particularly for ISO 13485-certified medical applications. Founded in 2008 and headquartered in Värnamo, Sweden, the company operates production facilities in Sweden and expands its reach across Europe and North America through strategic partnerships and customer collaborations.
In recent developments, KB Components strengthened its market position through a strategic acquisition of a complementary precision machining firm in late 2024, enhancing its capacity for medical device assemblies. The company also secured a significant funding round in early 2025 from existing investors to support facility expansions and new equipment investments aimed at increasing production efficiency. Additionally, KB Components launched an expanded range of additive manufacturing services integrated with traditional CNC processes, targeting growth in life science instrumentation as of mid-2025. These initiatives reflect the company's ongoing commitment to innovation and scalability in high-growth segments.